Ontology highlight
ABSTRACT: Background
statin treatment has increased also among people aged 80 years and over, but adverse effects potentially promoting frailty and loss of resilience are frequent concerns.Methods
in the Helsinki Businessmen Study, men born in 1919-34 (original n?=?3,490) have been followed up since the 1960s. In 2011, a random subcohort of home-living survivors (n?=?525) was assessed using questionnaires and clinical (including identification of phenotypic frailty) and laboratory examinations. A 7-year mortality follow-up ensued.Results
we compared 259 current statin users (median age 82 years, interquartile range 80-85 years) with 266 non-users (83; 80-86 years). Statin users had significantly more multimorbidity than non-users (prevalencies 72.1% and 50.4%, respectively, P?Conclusionsour study suggests that male octogenarian statin users preserved resilience and survival despite multimorbidity, and this may be associated with better nutritional status among statin users.
SUBMITTER: Luotola K
PROVIDER: S-EPMC7306181 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
Luotola Kari K Jyväkorpi Satu S Urtamo Annele A Pitkälä Kaisu H KH Kivimäki Mika M Strandberg Timo E TE
Age and ageing 20200201 2
<h4>Background</h4>statin treatment has increased also among people aged 80 years and over, but adverse effects potentially promoting frailty and loss of resilience are frequent concerns.<h4>Methods</h4>in the Helsinki Businessmen Study, men born in 1919-34 (original n = 3,490) have been followed up since the 1960s. In 2011, a random subcohort of home-living survivors (n = 525) was assessed using questionnaires and clinical (including identification of phenotypic frailty) and laboratory examinat ...[more]